Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Wied

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Orphanet Journal of Rare Diseases|December 20, 2024
Multi-stakeholder sessions on major innovation topics in rare disease clinical trialsDaniel Bodden, Stefanie Schoenen, Stephanie Wied, et al.
Atherosclerosis|July 4, 2021
Effects of empagliflozin on lipoprotein subfractions in patients with type 2 diabetes: data from a randomized, placebo-controlled studyMatthias Rau, Kirsten Thiele, Niels-Ulrik Korbinian Hartmann, et al.
Journal of Clinical Periodontology|September 13, 2021
Comparison of three full-mouth concepts for the non-surgical treatment of stage III and IV periodontitis: A randomized controlled trialJamal M Stein, Sareh Said Yekta-Michael, Florian Schittenhelm, et al.
Clinical Kidney Journal|May 22, 2023
Vitamin K1 and progression of cardiovascular calcifications in hemodialysis patients: the VitaVasK randomized controlled trialTurgay Saritas, Sebastian Reinartz, Thilo Krüger, et al.
Kidney International|May 26, 2020
After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathyThomas Rauen, Stephanie Wied, Christina Fitzner, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Orphanet Journal of Rare Diseases|December 20, 2024
Multi-stakeholder sessions on major innovation topics in rare disease clinical trialsDaniel Bodden, Stefanie Schoenen, Stephanie Wied, et al.
Atherosclerosis|July 4, 2021
Effects of empagliflozin on lipoprotein subfractions in patients with type 2 diabetes: data from a randomized, placebo-controlled studyMatthias Rau, Kirsten Thiele, Niels-Ulrik Korbinian Hartmann, et al.
Journal of Clinical Periodontology|September 13, 2021
Comparison of three full-mouth concepts for the non-surgical treatment of stage III and IV periodontitis: A randomized controlled trialJamal M Stein, Sareh Said Yekta-Michael, Florian Schittenhelm, et al.
Clinical Kidney Journal|May 22, 2023
Vitamin K1 and progression of cardiovascular calcifications in hemodialysis patients: the VitaVasK randomized controlled trialTurgay Saritas, Sebastian Reinartz, Thilo Krüger, et al.
Kidney International|May 26, 2020
After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathyThomas Rauen, Stephanie Wied, Christina Fitzner, et al.
Pageof 2